PolymarketVerifica disponibilitàSenza KYC2% di commissioneDati di risoluzione verificatiBen calibratoProbabilità implicita attuale
December 50%-0.5pt
Qualità del mercato
30 / 100
Bassa qualitàVolume 24h
237,8 €
Liquidità
135 €
Bassa liquiditàBid / Ask
14.0% / 85.0%
Spread
71.0 pt
Spread ampioCommenti
0
Variazione 7g
-2.0 pts
Dati di mercato
Aggiornato 13 minuti fa
23 giu 26, 02:13 UTC1 gen 27, 04:59 UTC
Trend
0%
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
When will the FDA reclassify BPC-157 to Category 1?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketWill the ACA premium tax credits be extended?
KalshiWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Anthony Fauci be arrested before 2029?
Manifold MarketsRegole
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.